Craig Arthur Townsend

This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent. Top assignees: Johns Hopkins University, Mars, Incorporated, Chektec Corporation. Active years: 1996-2021.

USPTO Granted Patents = 12 (Patent Applications = 8)

% Patents Active = 66.7

CIPO Patents = 1

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 35(Granted Patents)

Company Filing History:

9 out of 3,795

Johns Hopkins University

Rutgers, The State University of New Jersey

patents

where one patent can have more than one assignee

Years Active: 1996-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11084833 - Antibacterial agents against D,D- and L,D-transpeptidases (2021-08-10),

2. 10695322 - Inhibitors of bacterial growth (2020-06-30),

3. 9458479 - [object Object] (2016-10-04),

4. 9139588 - [object Object] (2015-09-22),

5. 7517680 - [object Object] (2009-04-14),

6. 7385086 - Antimicrobial compounds (2008-06-10),

7. 7282598 - Synthetic methods for preparing procyanidin oligomers (2007-10-16),

8. 7015338 - Synthetic methods for preparing procyanidin oligomers (2006-03-21),

9. 6864377 - Synthetic methods for preparing procyanidin oligomers (2005-03-08),

10. 6713654 - Antimicrobial compounds (2004-03-30),

11. 5981575 - Inhibition of fatty acid synthase as a means to reduce adipocyte mass (1999-11-09),

12. 5539132 - Cerulenin compounds for fatty acid synthesis inhibition (1996-07-23),

Title: Craig Arthur Townsend: Innovator in Antibacterial Agents

Introduction

Craig Arthur Townsend is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of antibacterial agents, holding a total of 12 patents. His work focuses on developing innovative solutions to combat bacterial infections.

Latest Patents

Among his latest patents are groundbreaking discoveries related to antibacterial agents against D,D- and L,D-transpeptidases. These patents disclose pharmaceutical compositions and methods for using these agents effectively. Additionally, he has developed new antimicrobials targeting L,D-transpeptidases and non-classical cysteine peptidases. His unique chemical structures for carbapenems and penems are particularly noteworthy, as they acylate and inhibit L,D-transpeptidases, likely resulting in superior antimicrobial potency. These new antimicrobial agents can be utilized alone or in combination with classic antimicrobial agents targeting D,D transpeptidases when treating bacterial infections.

Career Highlights

Throughout his career, Craig has worked with prestigious organizations, including The Johns Hopkins University and Mars, Incorporated. His innovative research has positioned him as a leader in the field of antimicrobial development.

Collaborations

Craig has collaborated with esteemed colleagues such as Francis P. Kuhajda and Gary R. Pasternack, further enhancing the impact of his work in the scientific community.

Conclusion

Craig Arthur Townsend's contributions to antibacterial research and his impressive portfolio of patents underscore his role as a significant innovator in the field. His work continues to pave the way for advancements in treating bacterial infections.